Zobrazeno 1 - 10
of 95
pro vyhledávání: '"CS Chiattone"'
Autor:
N Zing, T Fischer, E Miranda, Y Gonzaga, MA Dias, RLR Baptista, G Duffles, R Schaffel, FL Nogueira, D Bortucchi, RSA Silva, SAB Brasil, KZ Cecyn, VLP Figueiredo, NS Castro, YS Rabelo, GFS Barros, A Hallack-Neto, PPG Radtke, MALHM Conhalato, DV Clé, J Pereira, F Barroso, RR Sousa, H Quintero, D Castro, B Beltran, D Enriquez, J Vasquez, C Roche, D Artiles, F Valvert, L Villela, C Oliver, L Korin, C Pena, M Roa, MAT Viera, AV Glasenapp, A Quiroz, CS Figari, R Rios, S Paredes, EE Saul, C Bermack, K Meza, B Valcarcel, CA Souza, L Malpica, CS Chiattone
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S233-S234 (2024)
Introduction: Adult T-cell leukemia/lymphoma (ATLL) is a mature, peripheral T-cell neoplasm caused by HTLV-1 and its lifetime risk is estimated as 4-7% among HTLV-1 carriers. Acute and lymphoma subtypes are highly aggressive diseases, characterized b
Externí odkaz:
https://doaj.org/article/58c3427ca5c4476bba75d1029b8d3a5f
Autor:
T Fischer, E Miranda, J Pereira, G Duffles, JV Tavares, NS Castro, RSA Silva, DLC Farias, SAB Brasil, CCG Macedo, C Colaço, RLR Baptista, KZ Cecyn, D Bortucchi, GFS Barros, S Nabhan, PPG Radtke, R Schaffel, N Zing, FL Nogueira, AD Cunha-Junior, DV Clé, JTDS Filho, VLP Figueiredo, MD Pont, R Gaiolla, N Hamerschlak, EFO Ribeiro, A Hallack-Neto, MA Dias, Y Gonzaga, YS Rabelo, L Teixeira, G Perini, MALHM Conhalato, P Cury, H Idrobo, D Castro, B Beltran, D Enriquez, J Vasquez, C Roche, D Artiles, F Valvert, L Villela, C Oliver, L Korin, C Pena, M Roa, MAT Viera, AV Gasenapp, A Quiroz, CS Figari, R Rios, S Paredes, EE Saul, C Bermack, K Meza, B Valcarcel, CA Souza, L Malpica, CS Chiattone
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S256-S258 (2024)
Introduction: PTCL accounts for 10-15% of all NHL. As previously demonstrated, Latin America has its own epidemiological distribution, with a high frequency of ATLL and ENKT, likely influenced by distinct genetic profiles and viral epidemiology. 3-ye
Externí odkaz:
https://doaj.org/article/5f15d08093f549d3a333ac68a7b006be
Autor:
FM Marques, V Pfister, LLM Perobelli, V Buccheri, M Yamamoto, R Santucci, SC Fortier, CS Chiattone, MV Gonçalves, C Arrais-Rodrigues
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S329- (2024)
Introduction: In 2008, the International Workshop on Chronic Lymphocytic Leukemia (IWCLL) established criteria for treatment indications. The Brazilian CLL Group (GBLLC) has been evaluating a more conservative approach in the indication and initiatio
Externí odkaz:
https://doaj.org/article/b15a77cd9f834108a0e4658d23feb339
Autor:
V Pfister, FM Marques, R Santucci, V Buccheri, G Ribeiro, VLP Figueiredo, N Hamerschlak, A Costa, T Silveira, A Scheliga, L Perobelli, CS Chiattone, C Arrais-Rodrigues
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S327-S328 (2024)
Introduction: Ibrutinib, a Bruton's tyrosine kinase (BTK) inhibitor, is associated with increased survival and prolonged response, even in high-risk scenarios, with relatively low toxicity compared to chemoimmunotherapy. However, a significant number
Externí odkaz:
https://doaj.org/article/ed19c137f5f24762bd10e68c250f08cc
Autor:
FM Marques, V Pfister, LLM Perobelli, V Buccheri, R Santucci, GN Ribeiro, N Hamerschlak, MV Gonçalves, CS Chiattone, C Arrai-Rodrigues
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S176-S177 (2023)
Introduction: Chronic lymphocytic leukemia (CLL) exhibits diverse treatment requirements, with some patients receiving immediate treatment while others remain under observation. In 2008, the International Workshop on Chronic Lymphocytic Leukemia (IWC
Externí odkaz:
https://doaj.org/article/4508b080968547b58bbdfeb12e0306ec
Autor:
M Dibai, M Guarana, RL Baptista, V Mauad, MPQ Neto, AAK Johann, FB Duarte, E Nunes, CS Chiattone, M Nucci
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S244- (2023)
Introduction: The combination of venetoclax with hypomethylating agents (VEM-HM) is considered standard of care for unfit or elderly patients with acute myeloid leukemia (AML). However, in the real world, venetoclax-based regimens have been used also
Externí odkaz:
https://doaj.org/article/f8e1687fc93d47eea9ab2a5b778046ac
Autor:
CS Chiattone, E Miranda, SS Medina, RLR Baptista, J Pereira, SAB Brasil, JV Tavares, KZ Cecyn, FL Nogueira, M Bellosso, DFC Farias, D Borducchi, NS Castro, S Nabhan, PPG Rakde, CCG Macedo, CC Vilarim, M Dias, E Negreiros, VLP Figueiredo, DV Clé, R Schaffel, RD Gaiolla, S Schusterschitz, T Fischer, GF Silva, Y Gonzaga, N Zing, AD Cunha-Jr, JTD Souto-Filho, S Mo, EFO Ribeiro, FB Duarte, RR Sousa, MAL Matedi, MD Pont, N Hamerschlak, G Perini, YS Rabelo, ND Bueno, P Cury, A Hallack-Neto, MT Delamain, M Federico, CA Souza
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S332-S333 (2023)
Objectives: T-cell Brazil project started in April 2017 focusing to collecting epidemiological and clinical data from the most frequent subtypes of PTCL, as an ambispective study collected diagnosis data from January 2015 to December 2022. Our goals
Externí odkaz:
https://doaj.org/article/34934cf181a7482799c281eb9e495689
Autor:
T Fischer, E Miranda, NS Castro, J Pereira, D Borducchi, SS Medina, SAB Brasil, DFC Farias, M Bellesso, JV Tavares, KZ Cecyn, R Schaffel, S Nabhan, FL Nogueira, RLR Baptista, FB Duarte, RR Sousa, MD Pont, CC Vilarim, CCG Macedo, AD Cunh-Junior, PPG Radtke, E Negreiros, N Hamerschlak, VLP Figueiredo, DV Cle, N Zing, M Dias, RD Gaiolla, YBM Gonzaga, JTD Sout-Filho, EFO Ribeiro, GF Silva, S Mo, G Perini, MAL Matedi, A Hallac-Neto, YS Rabelo, M Federico, CA Souza, CS Chiattone
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S361-S362 (2023)
Objectives: To evaluate number of extranodal (EN) sites in nodal PTCL lymphomas (PTCL-NOS, TFH and ALCL ALK+/ALK-) and its specific location as a surrogate for overall survival (OS) and progression free survival (PFS). Also generate hypothesis for fu
Externí odkaz:
https://doaj.org/article/07b0cfa9f254491bbea5b8e5bcc51751
Autor:
T Fischer, H Idrobo, A Pavlovsky, D Castro, B Beltran, DJ Enriquez, JF Vasquez, C Roche, D Artiles, F Valvert, LM Villela, J Pereira, C Oliver, JV Tavares, SAB Brasil, KZ Cecyn, N Castro, RLR Baptista, SS Medina, DMM Borducchi, M Bellesso, DLC Farias, YB Gonzaga, F Warley, L Fiad, L Korin, PH Pereyra, C Pena, MA Torres, CV Mahuad, AV Glasenapp, AR Quiroz, R Gazitua, CA Samane-Figari, L Sardu, JP Arriola, S Isnardi, JL Maradei, RH Gabus, AI Enrico, LA Guanchiale, FN Arangueren, JIG Altuve, A Cerutti, R Penalva, JIG Trucco, F Pessolani, V Gilli, J Diaz, ME Martinez, G Jarchum, GC Perinotto, T Barraza, S Ciarlo, C Rojas, ROR Jiménez, CA Souza, ECM Miranda, M Federico, B Valcarcel, CS Chiattone, LEM Castillo
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S367-S368 (2023)
Objective: To assess the distribution of Peripheral T-cell lymphomas (PTCL) across Latin America (LATAM) countries and report treatment outcomes. Methods: Patients aged ≥18 years with newly diagnosed PTCL from the retrospective registry of the Grup
Externí odkaz:
https://doaj.org/article/70acf036dabd4e1e89445bd093fcd9df
Autor:
CS Chiattone, MT Delamain, ECM Miranda, J Pereira, DLC Farias, S Nabhan, M Bellesso, N Hamerschlak, N Zing, N Castro, G Ribeiro, RLR Baptista, Y Gonzaga, R Gaiolla, A Cordeiro, R Schaffel, JTD Souto-Filho, E Negreiros, A Hallack-Neto, EFO Ribeiro, CC Vilarim, CCG Macedo, SAB Brasil, SKG Mo, AD Cunha-Junior, P Cury, KZ Cecyn, G Duffles, M Federico, CA Souza
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S96-S97 (2021)
Introdução: O papel da terapia de altas doses (TAD) seguida pelo transplante de células tronco periférico (TCTP) autólogo como consolidação é ainda muito discutido para os pacientes com Linfoma de células T periféricas (LCTP), ou seja, não
Externí odkaz:
https://doaj.org/article/2e9d05da5077474a9735646a17549ac8